Skip to content
LATEST
US Politics

Medicare Advantage Insurer and Analytics Firm Settle Fraud Allegations for $100 Million

A Medicare Advantage insurer and a data analytics executive will pay up to $100 million to settle allegations of fraudulent billing for unsupported patient…

Medicare Advantage Insurer and Analytics Firm Settle Fraud Allegations for $100 Million

A New York-based Medicare Advantage provider and the CEO of a medical analytics firm have agreed to pay up to $100 million to resolve allegations of fraudulent billing practices. The settlement concludes a long-standing investigation into claims that the insurer submitted inflated or unsupported medical diagnoses to secure higher reimbursement rates from the federal government.

Under the terms of the agreement, the insurer will pay up to $98 million, with $34.5 million guaranteed in installments through 2028. The remaining balance is contingent upon the financial performance of the health plans. The CEO of the associated data mining firm, which specialized in reviewing medical records to identify additional diagnosis codes, will pay $2 million. Neither party admitted to wrongdoing as part of the settlement.

This marks one of the first instances where

The case originated from a whistleblower complaint alleging that the insurer and its analytics partner systematically exaggerated patient health conditions to increase revenue. The complaint specifically cited instances where resolved or non-existent conditions, such as chronic depression and renal failure, were coded to trigger higher payments. This marks one of the first instances where a data analytics firm has been held accountable for its role in facilitating alleged overcharges within the Medicare Advantage program.

This settlement highlights ongoing regulatory scrutiny regarding the accuracy of risk-adjustment coding in private Medicare plans. As the Medicare Advantage market continues to expand, federal oversight agencies are increasingly focused on the role of third-party data mining firms in the billing process. The whistleblower involved in the case is slated to receive at least $8.2 million for their role in the litigation. The analytics firm involved in the case ceased operations in 2021.

More stories

Latest news